Vericel Stock

Vericel Current Assets

The Current Assets of Vericel (VCEL) as of Aug 17, 2026 is 162.80 M USD. In the previous year, Current Assets was 212.78 M USD — a change of -23.49% (lower).

Current Assets

162.80 MUSD

YoY

-23.49%

Last updated:

Current Assets of Vericel is 2026 162.80 M USD. Current Assets of Vericel was 2025 212.78 M USD. It decreases by -23.49% lower compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

Current Assets of Vericel is 162.80 M USD in 2026.

Current Assets of Vericel changed from 212.78 M USD to 162.80 M USD, representing a -23.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Vericel since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Vericel historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vericel

All Key Metrics — Vericel